6-156829296-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001374828.1(ARID1B):c.1861C>T(p.Gln621*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001374828.1 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
- Coffin-Siris syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001374828.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARID1B | NM_001374828.1 | MANE Select | c.1861C>T | p.Gln621* | stop_gained | Exon 2 of 20 | NP_001361757.1 | ||
| ARID1B | NM_001438482.1 | c.1861C>T | p.Gln621* | stop_gained | Exon 2 of 21 | NP_001425411.1 | |||
| ARID1B | NM_001438483.1 | c.1861C>T | p.Gln621* | stop_gained | Exon 2 of 21 | NP_001425412.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARID1B | ENST00000636930.2 | TSL:2 MANE Select | c.1861C>T | p.Gln621* | stop_gained | Exon 2 of 20 | ENSP00000490491.2 | ||
| ARID1B | ENST00000346085.10 | TSL:1 | c.1861C>T | p.Gln621* | stop_gained | Exon 3 of 21 | ENSP00000344546.5 | ||
| ARID1B | ENST00000350026.11 | TSL:1 | c.1861C>T | p.Gln621* | stop_gained | Exon 2 of 19 | ENSP00000055163.8 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.1612C>T (p.Q538*) alteration, located in exon 2 (coding exon 2) of the ARID1B gene, consists of a C to T substitution at nucleotide position 1612. This changes the amino acid from a glutamine (Q) to a stop codon at amino acid position 538. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been reported de novo in association with Coffin-Siris syndrome (van der Sluijs, 2019; Lee, 2021). Based on the available evidence, this alteration is classified as pathogenic.
Coffin-Siris syndrome 1 Pathogenic:1
This variant was classified as: Pathogenic.
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30349098, 34706719)
Hypertrichosis;C0175754:Corpus callosum, agenesis of;C0557874:Global developmental delay;C1834405:Nail dysplasia;C2267233:Neonatal hypotonia Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at